Diagnostic Accuracy of Detective Flow Imaging Endoscopic Ultrasonography for Evaluating Blood Flow Within Mural Nodules of Intraductal Papillary Mucinous Neoplasms
<b>Background/Objectives:</b> Detective flow imaging (DFI) endoscopic ultrasonography (EUS) can identify the microvascular flow imaging of a mural nodule (MN) in an intraductal papillary mucinous neoplasm (IPMN) without the use of contrast agents. This retrospective study evaluated the diagnostic accuracy of DFI-EUS and its ability to evaluate the blood flow of MNs in IPMNs. <b>Methods:</b> Between April 2021 and September 2023, 68 patients with MNs in IPMNs observed on EUS images were retrospectively analyzed. Both DFI-EUS and contrast-enhanced EUS (CE-EUS) were performed during the same session. Three expert endosonographers blinded to the patients' clinical data assessed the MN images obtained with CE-EUS and DFI-EUS. First, DFI-EUS images were evaluated using a predefined scoring system; thereafter, CE-EUS images were evaluated. The diagnostic capability of DFI-EUS to detect MN blood flow was assessed with CE-EUS as the gold standard. Secondary outcomes included inter-reader agreement, the correlation between MN size and detection rates, and the association between DFI blood flow signal patterns and malignancy of MNs in surgically resected cases. <b>Results:</b> CE-EUS showed a contrast effect in the MN in 24 cases. Among these, DFI-EUS detected blood flow signals in 20 cases; false-positive results were not observed. DFI-EUS demonstrated a sensitivity of 83%, specificity of 100%, and accuracy of 93% for detecting MN blood flow. Inter-reader agreement was substantial (kappa values, 0.6-0.8). The subgroup analysis revealed that all MNs ≥ 10 mm had detectable blood flow on DFI-EUS, whereas MNs < 10 mm had reduced detection rates (75%; 12/16 cases). No significant correlation between the DFI blood flow signal patterns and MN malignancy of resected cases was observed. <b>Conclusions:</b> DFI-EUS demonstrated high diagnostic accuracy for detecting MN blood flow. Because of its simplicity and cost-effectiveness, DFI-EUS could be an alternative to CE-EUS for patients with MNs inside IPMNs.
Authors
- Kazushi Numata
- Kazuya Sugimori (ORCID: https://orcid.org/0000-0003-1596-0744)
- Yuichi Suzuki (ORCID: https://orcid.org/0009-0009-4456-5314)
- Shin Maeda (ORCID: https://orcid.org/0000-0002-0246-1594)
- Hayato Yoshimura
- Yugo Ishino (ORCID: https://orcid.org/0000-0003-0181-6573)
- Satoshi Komiyama (ORCID: https://orcid.org/0000-0003-1513-1751)
- Akihiro Funaoka
- Hiromi Tsuchiya
- Shotaro Tsunoda (ORCID: https://orcid.org/0000-0002-6366-2947)
- Kazuki Endo
- Shoichiro Yonei
- Keiichi Shibasaki
- Ritsuko Oishi (ORCID: https://orcid.org/0009-0009-7204-1112)
- Haruo Miwa (ORCID: https://orcid.org/0000-0001-6324-5433)
- Manabu Morimoto (ORCID: https://orcid.org/0000-0002-3940-9634)
- Takashi Kaneko
Institutions
- Yokohama City University Medical Center (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Diagnostics
- Published
- 2025-01-16
- DOI
- https://doi.org/10.3390/diagnostics15020196
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.14